Loading clinical trials...
Loading clinical trials...
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Clindamycin 1.2% and Benzoyl Peroxide 3.75% Gel to Onexton® Gel in Subjects With Acne Vulgaris
Conditions
Interventions
Onexton
Clindamycin/benzoyl peroxide gel
+1 more
Locations
17
United States
Alliance Dermatology
Phoenix, Arizona, United States
Estudy
Chula Vista, California, United States
Estudy
La Mesa, California, United States
Tampa Bay Medical Research
Clearwater, Florida, United States
AMB Research Center
Miami, Florida, United States
Meridian Clinical Research
Savannah, Georgia, United States
Start Date
May 1, 2015
Primary Completion Date
October 1, 2015
Completion Date
November 1, 2015
Last Updated
May 27, 2020
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
Actavis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions